Citrobacter Youngae Test

Most people will never need to think about Citrobacter youngae. It is a rare bacterium that lives quietly in soil, water, food, and the human intestine, usually without causing any problem. The reason it gets attention at all is that, under the right circumstances, it can turn into a serious infection.

When this microbe shows up on a stool microbiome test, it adds one specific piece to a much bigger picture of your gut. It is an exploratory marker rather than a diagnostic one, but tracking it alongside other gut measurements can help you spot patterns of disturbance that you might otherwise miss.

What This Bacterium Is

C. youngae (Citrobacter youngae) is a gram-negative coliform, meaning it is part of the Enterobacteriaceae family of bacteria that lives in the gut and is detectable on standard cultures. It was first described as a distinct species in 1993 and remains one of the lesser-known members of the Citrobacter genus.

Most Citrobacter infections in humans are caused by two of its cousins, C. freundii and C. koseri. C. youngae itself is rare in clinical samples. In one Indian hospital review of 205 Citrobacter infections, C. youngae was absent. Greek surveillance has identified only a handful of isolates, with very few bloodstream cases on record.

When It Becomes a Problem

When C. youngae causes disease, it is almost always opportunistic, meaning it takes advantage of a body that is somehow vulnerable. Reported cases involve the intestinal tract, the urinary and genital tracts, and on rare occasion, deeper sites like the bloodstream or spine.

A 2024 case report described a 70-year-old man who developed a serious bloodstream infection along with pyogenic spondylodiscitis (an infection of an intervertebral disc and the adjacent vertebrae) after a minimally invasive lumbar microdiscectomy. The bacterium most likely entered directly at the surgical site rather than traveling from somewhere else. Another report described peritonitis (infection of the lining of the abdomen) in a peritoneal dialysis patient, where C. youngae was a co-pathogen with another bacterium called Pantoea agglomerans.

Across the available human evidence, the people at highest risk are those who are immunocompromised, recovering from surgery, or undergoing invasive procedures like dialysis. In otherwise healthy people, presence of C. youngae in the gut is not in itself a sign of disease.

The Antibiotic Resistance Concern

One reason clinicians track Citrobacter species at all is rising antibiotic resistance. In the postoperative spinal infection case above, the bacterium was resistant to third-generation cephalosporins like ceftriaxone and cefotaxime, but still susceptible to ceftazidime, ciprofloxacin, fourth-generation cephalosporins, gentamicin, and carbapenems. C. youngae carrying an enzyme called IMP-4 carbapenemase, which can break down even carbapenem antibiotics, has been reported.

What this means for you: if a stool microbiome test flags C. youngae and you also develop an infection later, that previous identification can give your clinician a head start on choosing the right antibiotic, especially if the strain has a known resistance pattern.

Tracking Your Levels

A single stool test is a snapshot. The gut microbiome shifts day to day with diet, stress, medications, illness, and travel. One reading showing C. youngae present, or absent, says relatively little on its own. What is more useful is watching whether this bacterium and others in the Enterobacteriaceae family trend up or down as you change your medications, recover from an illness, or shift your diet.

A reasonable cadence: get a baseline, retest in 3 to 6 months if you are making targeted gut-health changes or starting or stopping a medication known to alter the microbiome, then at least annually. If you start a course of antibiotics or have an invasive procedure, that is another natural time to retest, because both can reshape what grows in your gut.

When Results Can Be Misleading

A handful of factors can shift what your stool test shows without reflecting any real change in your gut health:

• Recent antibiotics: courses of antibiotics taken in the days or weeks before testing can suppress some gut bacteria and allow others, including Citrobacter species, to expand temporarily.
• Sample handling: stool samples that are not collected, stored, or shipped according to instructions can yield unreliable results, with some organisms over- or under-represented.
• Recent illness or travel: an acute infection or recent travel-related microbiome disturbance can shift gut bacteria in ways that normalize within weeks.
• Medications that broadly shift gut bacteria: a systematic review found that several common non-antibiotic drugs are linked to changes in Gammaproteobacteria, the broader bacterial class that includes Citrobacter. This means the number on your test may reflect your medication exposure as much as your baseline gut state.

Decision Pathway for an Abnormal Result

If C. youngae shows up on your microbiome panel and you feel well, the result usually does not require action. The bacterium is part of the normal environmental and intestinal flora for many people. Where the result becomes worth investigating is in context.

Pair it with the rest of your panel. If C. youngae is elevated alongside a high dysbiosis score, elevated calprotectin (a marker of gut inflammation), low beneficial species like Faecalibacterium prausnitzii or Akkermansia muciniphila, or symptoms like persistent diarrhea, abdominal pain, or unexplained weight loss, that pattern is worth taking to a gastroenterologist for a more complete workup. If you are about to undergo surgery, are on dialysis, or are immunocompromised, share microbiome results with your surgical or transplant team so they can factor them into perioperative planning. A positive blood or tissue culture for C. youngae, by contrast, is always abnormal and requires antibiotic susceptibility testing and targeted treatment, typically directed by an infectious disease specialist.